speb/financial-data huggingface dataset:
Financial ratios for HBNC — quarterly report dated 2025-12-31
Total revenue: 73755000
Net income: 26922000
Capital expenditures: 943000
Operating cash flow: 33573000
Depreciation & amortization: 1199000
Net tangible assets: 525860000
Owner earnings: 27178000
Return on net tangible assets (%): 5.1682957441144035
Buffett classification: The Gruesome
Stock price: 16.51
P/E ratio: 7.869534243741179
Shares outstanding: 51329764
Book value: 688251000
P/B ratio: 1.2313159060284693
Market cap (USD): 847454403.6400001
Debt to equity: 0.4589197836254506
Effective tax rate (%): 17.657134118366724
COGS to revenue (%): 0
SG&A to revenue (%): 31.38092332723205
Free cash flow (dilution-adjusted): 32173000
Buyback yield (%): 0
Retained earnings: 255004000
Receivables turnover: 2.4805771365149836
Capitalized R&D asset: 0
FCF margin (%): 43.62144939326147
Rule of 40 score: 43.62144939326147
Financial ratios for HBNC — annual report dated 2025-12-31
Total revenue: -31306000
Net income: -150482000
Capital expenditures: 4956000
Operating cash flow: 79231000
Depreciation & amortization: 12399000
Net tangible assets: 525860000
Owner earnings: -143039000
Return on net tangible assets (%): -27.200966036587687
Buffett classification: The Gruesome
Stock price: 16.51
Shares outstanding: 51329764
Book value: 688251000
P/B ratio: 1.2313159060284693
Market cap (USD): 847454403.6400001
Debt to equity: 0.4589197836254506
Free cash flow (dilution-adjusted): 72654000
Buyback yield (%): 0
Retained earnings: 255004000
Receivables turnover: -1.0529041805401407
Capitalized R&D asset: 0
Revenue growth (%): -116.69662238198603
Rule of 40 score: -116.69662238198603
Financial ratios for HYN.OL — annual report dated 2021-12-31
Total revenue: 195720.22727272726
Gross profit: -306612.8409090909
Operating income: -1920206.5909090908
Net income: -1909820.5681818181
Capital expenditures: 1055312.9545454544
Operating cash flow: -2191246.477272727
Depreciation & amortization: 49785.79545454545
Net tangible assets: 6375427.2727272725
Owner earnings: -2915347.727272727
Return on net tangible assets (%): -45.727879913930906
Buffett classification: The Gruesome
Stock price: 0.2291904218928164
Shares outstanding: 750583252
Book value: 6399793.068181817
P/B ratio: 26.88000851884339
Market cap (USD): 172026492.19156215
Debt to equity: 0
Current ratio: 9.140093192710022
Quick ratio: 9.131129161633774
Interest coverage ratio: -948.3566056796499
COGS to revenue (%): 256.6587394576442
Free cash flow (dilution-adjusted): -3246559.4318181816
Buyback yield (%): 0
Inventory turnover: 96.57296718661247
Receivables turnover: 12.024393138644346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -29.924496059984513
FCF margin (%): -1658.7756294060746
Rule of 40 score: -1658.7756294060746
Financial ratios for HYN.OL — annual report dated 2022-12-31
Total revenue: 420677.1255060728
Gross profit: -387730.0607287449
Operating income: -2860204.655870445
Net income: -2954696.862348178
Capital expenditures: 1329291.0931174087
Operating cash flow: -2532071.963562753
Depreciation & amortization: 177130.56680161942
Net tangible assets: 5620802.024291498
Owner earnings: -4106857.388663967
Return on net tangible assets (%): -73.06532717066541
Buffett classification: The Gruesome
Stock price: 0.06477732793522267
Shares outstanding: 750583252
Book value: 5637830.263157894
P/B ratio: 8.62402292868181
Market cap (USD): 48620777.45748988
Debt to equity: 0
Current ratio: 3.1746822319051007
Quick ratio: 3.165967570763507
Interest coverage ratio: -44.841962782475676
COGS to revenue (%): 192.1680874048731
Free cash flow (dilution-adjusted): -3861363.0566801615
Buyback yield (%): 0
Inventory turnover: 64.44870046558917
Receivables turnover: 3.024681160738652
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -50.59611457564912
FCF margin (%): -917.8923270512886
Revenue growth (%): 114.93799152393089
Rule of 40 score: -802.9543355273577
Financial ratios for ICG — annual report dated 2023-12-31
Total revenue: 11564697.609001406
Gross profit: 1276793.2489451477
Operating income: -7280872.011251758
Net income: -3768635.7243319266
Capital expenditures: 6596061.884669479
Operating cash flow: -662165.9634317862
Depreciation & amortization: 538677.9184247538
Net tangible assets: 133087904.36005625
Owner earnings: -9826019.690576652
Return on net tangible assets (%): -7.383104976988232
Buffett classification: The Gruesome
Stock price: 12.37
Shares outstanding: 28715807
Book value: 133660337.55274262
P/B ratio: 2.657591167984531
Market cap (USD): 355214532.59
Debt to equity: 0.001961434246178939
Current ratio: 27.606731998295697
Quick ratio: 26.12373952563556
Interest coverage ratio: -834.9516129032257
COGS to revenue (%): 88.95956217695348
R&D to revenue (%): 51.44907266646397
SG&A to revenue (%): 38.603830951657045
Free cash flow (dilution-adjusted): -8228551.336146273
Buyback yield (%): 0
Retained earnings: 100416315.04922643
Inventory turnover: 1.7513108434888789
Receivables turnover: 5.944119135400853
Capitalized R&D asset: 10607873.642029196
ROCI (R&D-adjusted, %): -3.9006945693441835
Rosenberg metric: -7.808554342847081
FCF margin (%): -71.15232593493464
Revenue growth (%): -83.00960540409301
Rule of 40 score: -154.16193133902766
Financial ratios for ICG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.47
Shares outstanding: 28715807
Market cap (USD): 128359657.28999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICG — quarterly report dated 2024-12-31
Total revenue: 10161232.87671233
Gross profit: 2660958.9041095893
Operating income: -3932191.780821918
Net income: 1750821.9178082193
Capital expenditures: 723972.6027397261
Operating cash flow: -3080000
Depreciation & amortization: 174246.57534246575
Net tangible assets: 117907534.24657534
Owner earnings: 1201095.8904109588
Return on net tangible assets (%): 1.0186761160649451
Buffett classification: The Gruesome
Stock price: 3.3
P/E ratio: 13.531096757491587
Shares outstanding: 28715807
Book value: 138776301.369863
P/B ratio: 0.682841105899215
Market cap (USD): 94762163.1
Debt to equity: 0.00026849162000144123
Current ratio: 9.430679469401637
Quick ratio: 8.140629496873444
Effective tax rate (%): -226.7962158015853
COGS to revenue (%): 73.81263734041549
R&D to revenue (%): 61.861493454844485
SG&A to revenue (%): 13.661916766652734
Free cash flow (dilution-adjusted): -4076986.301369863
Buyback yield (%): 0
Retained earnings: 104423561.64383562
Inventory turnover: 0.5552152838339384
Receivables turnover: 2.615826779983778
Capitalized R&D asset: 6285890.410958904
ROCI (R&D-adjusted, %): 0.17813175391313785
FCF margin (%): -40.12294916213921
Rule of 40 score: -40.12294916213921
Financial ratios for ICG — annual report dated 2024-12-31
Total revenue: 38598219.17808219
Gross profit: 20728082.191780824
Operating income: 1513287.6712328768
Net income: 7054383.561643836
Capital expenditures: 1380410.9589041097
Operating cash flow: -18938767.12328767
Depreciation & amortization: 682602.7397260274
Net tangible assets: 117907534.24657534
Owner earnings: 6356575.342465754
Return on net tangible assets (%): 5.391152807226467
Capex to operating income (%): 91.21933556621707
Buffett classification: The Gruesome
Stock price: 3.3
P/E ratio: 13.433089124220826
Shares outstanding: 28715807
Book value: 138776301.369863
P/B ratio: 0.682841105899215
Market cap (USD): 94762163.1
Debt to equity: 0.00026849162000144123
Current ratio: 9.430679469401637
Quick ratio: 8.140629496873444
Effective tax rate (%): -2.630687366721805
Interest coverage ratio: 197.26785714285714
COGS to revenue (%): 46.29782763772905
R&D to revenue (%): 38.841667051145095
SG&A to revenue (%): 13.740430923422545
Free cash flow (dilution-adjusted): -21548493.15068493
Buyback yield (%): 0
Retained earnings: 104423561.64383562
Inventory turnover: 1.3228547670716124
Receivables turnover: 9.93641781570688
Capitalized R&D asset: 21272855.870981477
ROCI (R&D-adjusted, %): 4.503233485505405
Rosenberg metric: 3.2691628305493965
FCF margin (%): -55.82768741548868
Revenue growth (%): 233.7590007372021
Rule of 40 score: 177.9313133217134
Financial ratios for ICG — quarterly report dated 2025-03-31
Total revenue: 18235674.931129478
Gross profit: 10378236.914600551
Operating income: 5084986.225895317
Net income: -4682782.369146005
Capital expenditures: 0
Net tangible assets: 121233471.07438017
Owner earnings: -4682782.369146005
Return on net tangible assets (%): -3.8626151075662807
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.71
Shares outstanding: 28715807
Book value: 135694903.58126724
P/B ratio: 0.573491228603099
Market cap (USD): 77819836.97
Debt to equity: 0
Current ratio: 13.596359581143917
Quick ratio: 11.848089063622274
COGS to revenue (%): 43.088276393410425
R&D to revenue (%): 19.9061869764561
SG&A to revenue (%): 9.12071062232327
Buyback yield (%): 0
Retained earnings: 100295454.54545455
Inventory turnover: 0.6167427076350899
Capitalized R&D asset: 7841574.1235518325
ROCI (R&D-adjusted, %): 3.768873163266732
Rosenberg metric: 1.2277143739312664
Revenue growth (%): 79.46321231277238
Rule of 40 score: 79.46321231277238
Financial ratios for ICG — quarterly report dated 2025-06-30
Total revenue: 6024686.192468619
Gross profit: 1435146.4435146444
Operating income: -2253417.0153417015
Net income: 5335006.973500697
Capital expenditures: 0
Net tangible assets: 120734449.09344491
Owner earnings: 5335006.973500697
Return on net tangible assets (%): 4.41879431559054
Buffett classification: The Gruesome
Stock price: 1.79
P/E ratio: 21.390053857024466
Shares outstanding: 28715807
Book value: 143192329.1492329
P/B ratio: 0.3589668164167534
Market cap (USD): 51401294.53
Debt to equity: 0
Current ratio: 20.567128364011907
Quick ratio: 16.56299738776502
Effective tax rate (%): -29.303992157658115
COGS to revenue (%): 76.17890131259115
R&D to revenue (%): 35.27559784244277
SG&A to revenue (%): 25.948561242678892
Buyback yield (%): 0
Retained earnings: 106884797.76847978
Inventory turnover: 0.24962829226847918
Capitalized R&D asset: 6631706.365441122
ROCI (R&D-adjusted, %): -2.764505445217782
Rosenberg metric: -2.4636425901223222
Revenue growth (%): -66.96208824064917
Rule of 40 score: -66.96208824064917
Financial ratios for ICG — quarterly report dated 2025-09-30
Total revenue: 1284410.1123595505
Gross profit: -1274578.6516853932
Operating income: -5867415.730337079
Net income: 10453932.584269663
Capital expenditures: 0
Net tangible assets: 117432443.82022472
Owner earnings: 10453932.584269663
Return on net tangible assets (%): 8.902082119889632
Buffett classification: The Gruesome
Stock price: 1.7
P/E ratio: 3.796916172600456
Shares outstanding: 28715807
Book value: 154892134.83146065
P/B ratio: 0.315166886640939
Market cap (USD): 48816871.9
Debt to equity: 0
Current ratio: 16.530783605332005
Quick ratio: 13.289373364893482
Effective tax rate (%): -7.8084037021479995
COGS to revenue (%): 199.23455440131218
R&D to revenue (%): 247.6872607982504
SG&A to revenue (%): 109.89611809732094
Buyback yield (%): 0
Retained earnings: 118091994.38202247
Inventory turnover: 0.14005257736713453
Capitalized R&D asset: 5803142.844219545
ROCI (R&D-adjusted, %): -3.5252806031646133
Rosenberg metric: -1.2750183050652493
Revenue growth (%): -78.68087944621622
Rule of 40 score: -78.68087944621622
Financial ratios for INDOFARM.NS — quarterly report dated 2025-03-31
Total revenue: 15193663.783025485
Gross profit: 5682534.486789806
Operating income: 1802267.944821136
Net income: 1579483.282674772
Capital expenditures: 0
Depreciation & amortization: 351250.87678279163
Net tangible assets: 61330640.63595978
Owner earnings: 1930734.1594575637
Return on net tangible assets (%): 3.1480743384335743
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8067452444859375
P/E ratio: 13.741360978971624
Shares outstanding: 48051600
Book value: 62116799.15828852
P/B ratio: 1.39764123339179
Market cap (USD): 86816999.78994048
Debt to equity: 0.3264005769486649
Current ratio: 2.7933296708022577
Quick ratio: 1.745659022394944
Effective tax rate (%): -13.819131460342868
Interest coverage ratio: 2.988639888337469
COGS to revenue (%): 62.599313977591166
Buyback yield (%): 0
Retained earnings: 29178606.499883093
Inventory turnover: 0.47037241530825513
Receivables turnover: 1.205945913344437
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.583224306832744
Rule of 40 score: 0
Financial ratios for INDOFARM.NS — annual report dated 2025-03-31
Total revenue: 45264110.35772738
Gross profit: 18815910.68505962
Operating income: 5547860.6499883095
Net income: 2752723.871872808
Capital expenditures: 3132090.2501753564
Operating cash flow: 6196153.846153846
Depreciation & amortization: 1264297.4047229365
Net tangible assets: 61330640.63595978
Owner earnings: 884931.0264203879
Return on net tangible assets (%): 1.4428856722255228
Capex to operating income (%): 56.45582050050151
Buffett classification: The Good
Stock price: 1.8067452444859375
P/E ratio: 31.53857917862091
Shares outstanding: 48051600
Book value: 62116799.15828852
P/B ratio: 1.39764123339179
Market cap (USD): 86816999.78994048
Debt to equity: 0.3264005769486649
Current ratio: 2.7933296708022577
Quick ratio: 1.745659022394944
Effective tax rate (%): 10.007872992577985
Interest coverage ratio: 1.9845688692619405
COGS to revenue (%): 58.43083949655621
R&D to revenue (%): 0.2760924116685073
SG&A to revenue (%): 11.040958787073606
Free cash flow (dilution-adjusted): 3057271.451952303
Buyback yield (%): 0
Retained earnings: 29178606.499883093
Inventory turnover: 1.3079943688192155
Receivables turnover: 3.5926863781240868
Capitalized R&D asset: 187168.96537304437
ROCI (R&D-adjusted, %): 7.9910064078513505
Rosenberg metric: 20.108089230079695
FCF margin (%): 6.754294799545028
Revenue growth (%): 0.7392603898151446
Rule of 40 score: 7.493555189360173
Financial ratios for INDOFARM.NS — quarterly report dated 2025-06-30
Total revenue: 11263877.837584836
Gross profit: 4895623.683594665
Operating income: 1190861.2216241518
Net income: 635829.6278960918
Capital expenditures: 0
Depreciation & amortization: 349613.8544348233
Owner earnings: 985443.482330915
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.9728527966300025
P/E ratio: 37.27363796974493
Shares outstanding: 48051600
Market cap (USD): 94798733.44254623
Effective tax rate (%): 27.73337234509449
Interest coverage ratio: 2.306738593349804
COGS to revenue (%): 56.53696041287706
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -25.86463674305499
Rule of 40 score: -25.86463674305499
Financial ratios for INDOFARM.NS — quarterly report dated 2025-09-30
Total revenue: 11713043.96843292
Gross profit: 4660473.506200676
Operating income: 1096696.730552424
Net income: 561995.4904171363
Capital expenditures: 0
Depreciation & amortization: 343010.14656144305
Net tangible assets: 60235095.82863585
Owner earnings: 905005.6369785795
Return on net tangible assets (%): 1.5024557104603102
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.4910935738444193
P/E ratio: 43.09965430211497
Shares outstanding: 48051600
Book value: 61078444.19391206
P/B ratio: 1.9597917653716792
Market cap (USD): 119701031.9729425
Debt to equity: 0.33236280326295975
Current ratio: 2.6620570527932412
Quick ratio: 1.6676899673406336
Effective tax rate (%): 30.473653379452703
Interest coverage ratio: 2.2039285876115824
COGS to revenue (%): 60.21125235454744
Buyback yield (%): 0
Inventory turnover: 0.35236196744063963
Receivables turnover: 0.8313664392495396
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6046651535588856
Revenue growth (%): 3.9876686992229704
Rule of 40 score: 3.9876686992229704
Financial ratios for INDOFARM.NS — quarterly report dated 2025-12-31
Total revenue: 117936838.58750139
Gross profit: 49451821.321154065
Operating income: 11670714.047009023
Net income: 6189707.029074301
Capital expenditures: 0
Depreciation & amortization: 3389216.887601649
Owner earnings: 9578923.91667595
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.315807062493038
P/E ratio: 12.409729358892974
Shares outstanding: 48051600
Market cap (USD): 111278234.64409046
Effective tax rate (%): 29.280523348309174
Interest coverage ratio: 2.3921819344232347
COGS to revenue (%): 58.069232723697226
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 906.8846228644361
Rule of 40 score: 906.8846228644361
Financial ratios for ISE.MC — annual report dated 2022-06-30
Total revenue: 0
Gross profit: 0
Operating income: -521085.4166666667
Net income: -5690292.708333334
Capital expenditures: 154569.7916666667
Operating cash flow: -4438000
Depreciation & amortization: 2019233.3333333335
Net tangible assets: -14998636.458333334
Owner earnings: -3825629.166666667
Buffett classification: The Gruesome
Stock price: 0.5416666666666667
Shares outstanding: 57686300
Book value: -8635137.5
Market cap (USD): 31246745.833333336
Debt to equity: -1.3978857217579532
Current ratio: 0.424980868711609
Quick ratio: 0.424980868711609
Interest coverage ratio: -21.142941673710904
Free cash flow (dilution-adjusted): -4592569.791666667
Buyback yield (%): 0
Retained earnings: -5690292.708333334
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.88908459368395
Rule of 40 score: 0
Financial ratios for ISE.MC — annual report dated 2023-06-30
Total revenue: 0
Gross profit: 0
Operating income: 33695.65217391304
Net income: -8100000
Capital expenditures: 0
Operating cash flow: -618478.2608695652
Depreciation & amortization: 1086.9565217391305
Net tangible assets: -17100127.173913043
Owner earnings: -8098913.043478261
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6195652173913042
Shares outstanding: 57686300
Book value: -17098380.43478261
Market cap (USD): 35740424.99999999
Debt to equity: -0.27993002134069395
Current ratio: 0.20415880987297844
Quick ratio: 0.20415880987297844
Effective tax rate (%): 0
Interest coverage ratio: 0.17714285714285713
Free cash flow (dilution-adjusted): -618478.2608695652
Buyback yield (%): 0
Retained earnings: -8099508.695652174
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JSG.L — annual report dated 2021-12-31
Gross profit: 132837837.83783785
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.01783783783783784
Shares outstanding: 366134204
Market cap (USD): 6531042.557837838
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JSG.L — annual report dated 2022-12-31
Total revenue: 464698795.1807229
Gross profit: 178674698.79518074
Operating income: 40963855.421686746
Net income: 34939759.03614458
Capital expenditures: 26144578.31325301
Operating cash flow: 113855421.686747
Depreciation & amortization: 85421686.74698795
Net tangible assets: 168554216.86746988
Owner earnings: 94216867.46987951
Return on net tangible assets (%): 55.89706933523944
Capex to operating income (%): 63.8235294117647
Buffett classification: The Good
Stock price: 0.010602409638554218
P/E ratio: 0.11110279293793106
Shares outstanding: 366134204
Book value: 342891566.26506025
P/B ratio: 0.011321085717498245
Market cap (USD): 3881904.8134939764
Debt to equity: 0.19009135628952917
Current ratio: 0.8013100436681223
Quick ratio: 0.7816593886462883
Effective tax rate (%): 4.9504950495049505
Interest coverage ratio: 12.142857142857142
COGS to revenue (%): 61.550427793621985
SG&A to revenue (%): 27.76769509981851
Free cash flow (dilution-adjusted): 84337349.39759035
Buyback yield (%): 173.8061151925692
Retained earnings: 266987951.80722892
Inventory turnover: 131.88888888888889
Receivables turnover: 7.346666666666666
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.944428195378766
FCF margin (%): 18.148820326678763
Rule of 40 score: 18.148820326678763
Financial ratios for JSG.L — annual report dated 2023-12-31
Total revenue: 588987341.7721518
Gross profit: 227088607.5949367
Operating income: 50632911.39240506
Net income: 34556962.025316454
Capital expenditures: 39113924.05063291
Operating cash flow: 153670886.07594937
Depreciation & amortization: 109240506.32911392
Net tangible assets: 146329113.92405063
Owner earnings: 104683544.30379747
Return on net tangible assets (%): 71.53979238754326
Capex to operating income (%): 77.25
Buffett classification: The Gruesome
Stock price: 0.01658227848101266
P/E ratio: 0.1756907718827839
Shares outstanding: 366134204
Book value: 353291139.24050623
P/B ratio: 0.017185088041562168
Market cap (USD): 6071339.332151899
Debt to equity: 0.4102472232174849
Current ratio: 0.8765541740674955
Quick ratio: 0.8596802841918294
Effective tax rate (%): 27.659574468085108
Interest coverage ratio: 7.017543859649123
COGS to revenue (%): 61.444229529335914
SG&A to revenue (%): 27.702557489791534
Free cash flow (dilution-adjusted): 113037974.6835443
Buyback yield (%): 623.3896541639696
Retained earnings: 273670886.0759494
Inventory turnover: 150.4736842105263
Receivables turnover: 6.965568862275449
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.090817356205854
FCF margin (%): 19.191919191919194
Revenue growth (%): 26.746044508915222
Rule of 40 score: 45.937963700834416
Financial ratios for JSG.L — annual report dated 2024-12-31
Total revenue: 641750000
Operating income: 60875000
Net income: 44500000
Capital expenditures: 55250000
Operating cash flow: 177250000
Depreciation & amortization: 121875000
Net tangible assets: 155375000
Owner earnings: 111125000
Return on net tangible assets (%): 71.52051488334675
Capex to operating income (%): 90.75975359342917
Buffett classification: The Gruesome
Stock price: 0.016
P/E ratio: 0.13164375874157305
Shares outstanding: 366134204
Book value: 383625000
P/B ratio: 0.015270504435320952
Market cap (USD): 5858147.264
Debt to equity: 0.41414141414141414
Current ratio: 0.8714788732394366
Quick ratio: 0.8512323943661971
Effective tax rate (%): 24.78813559322034
Interest coverage ratio: 6.859154929577465
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 112125000
Buyback yield (%): 0
Retained earnings: 303750000
Inventory turnover: 0
Receivables turnover: 7.984447900466563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.853577000222867
FCF margin (%): 17.471756914686402
Revenue growth (%): 8.958199011390514
Rule of 40 score: 26.429955926076914
Financial ratios for JSG.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 155375000
Buffett classification: The Gruesome
Stock price: 0.016
Shares outstanding: 366134204
Book value: 383625000
P/B ratio: 0.015270504435320952
Market cap (USD): 5858147.264
Debt to equity: 0.41414141414141414
Current ratio: 0.8714788732394366
Quick ratio: 0.8512323943661971
Buyback yield (%): 0
Retained earnings: 303750000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JSG.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 153150684.93150684
Buffett classification: The Gruesome
Stock price: 0.020136986301369862
Shares outstanding: 366134204
Book value: 402328767.1232876
P/B ratio: 0.018325409597548522
Market cap (USD): 7372839.450410958
Debt to equity: 0.5328566564521622
Current ratio: 0.9327165685449958
Quick ratio: 0.8965517241379309
Buyback yield (%): 0
Retained earnings: 314520547.9452055
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KAPSTON.NS — annual report dated 2022-03-31
Total revenue: 35673466.9655809
Gross profit: 34948938.41487538
Operating income: 1001239.6149281288
Net income: 326176.9748120797
Capital expenditures: 211433.4696030595
Operating cash flow: -3016167.743637083
Depreciation & amortization: 719609.653171568
Net tangible assets: 7061057.628906765
Owner earnings: 834353.1583805882
Return on net tangible assets (%): 11.816263260122517
Capex to operating income (%): 21.117169801380328
Buffett classification: The Great
Stock price: 0.4520638269814058
P/E ratio: 42.17737661680278
Shares outstanding: 30432183
Book value: 7061044.441513911
P/B ratio: 1.9483362871214094
Market cap (USD): 13757289.11037848
Debt to equity: 1.5820812454826794
Current ratio: 1.470272234273319
Quick ratio: 1.4312017353579176
Effective tax rate (%): -150.42016806722688
Interest coverage ratio: 1.1852753840389658
COGS to revenue (%): 2.0310012239757294
SG&A to revenue (%): 0.7815922330958452
Free cash flow (dilution-adjusted): -3231557.4310958725
Buyback yield (%): 0
Retained earnings: 4626348.4109191615
Inventory turnover: 1.525164478250007
Receivables turnover: 2.9273898570674146
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.807779141174162
FCF margin (%): -9.058714237710062
Rule of 40 score: -9.058714237710062
Financial ratios for KAPSTON.NS — annual report dated 2023-03-31
Total revenue: 48337612.66747869
Gross profit: 47370609.0133983
Operating income: 1149585.8708891596
Net income: 617576.1266747869
Capital expenditures: 149220.46285018272
Operating cash flow: 182752.74056029235
Depreciation & amortization: 524238.73325213155
Net tangible assets: 7145237.515225335
Owner earnings: 992594.3970767357
Return on net tangible assets (%): 13.891692123063496
Capex to operating income (%): 12.980366811116644
Buffett classification: The Great
Stock price: 0.5535931790499392
P/E ratio: 27.279307286551095
Shares outstanding: 30432183
Book value: 7145237.515225334
P/B ratio: 2.3578011082908312
Market cap (USD): 16847048.932399515
Debt to equity: 1.5725933476980145
Current ratio: 1.4158927999377822
Quick ratio: 1.3705273897899588
Effective tax rate (%): -115.87686805466855
Interest coverage ratio: 1.0716467395623983
COGS to revenue (%): 2.000520093395066
SG&A to revenue (%): 0.7929156425648063
Free cash flow (dilution-adjusted): 26053.59317904994
Buyback yield (%): 0
Retained earnings: 4890609.013398295
Inventory turnover: 1.6202906241071064
Receivables turnover: 3.7972542392991304
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.182090536174945
FCF margin (%): 0.05389921376191313
Revenue growth (%): 35.50018200954964
Rule of 40 score: 35.554081223311556
Financial ratios for KAPSTON.NS — annual report dated 2024-03-31
Total revenue: 62256145.82084183
Gross profit: 61187648.39908862
Operating income: 2270020.3861374264
Net income: 1507458.9279290084
Capital expenditures: 205072.55066554743
Operating cash flow: 468989.087420554
Depreciation & amortization: 433757.0452092577
Net tangible assets: 8583271.375464683
Owner earnings: 1736143.4224727186
Return on net tangible assets (%): 20.227059666731403
Capex to operating income (%): 9.033951937959927
Buffett classification: The Great
Stock price: 0.9690499040307102
P/E ratio: 19.562923718332854
Shares outstanding: 30432183
Book value: 8583283.367310228
P/B ratio: 3.435783575305226
Market cap (USD): 29490304.01559501
Debt to equity: 1.428118363697329
Current ratio: 1.4003956534908375
Quick ratio: 1.360614177898935
Effective tax rate (%): -26.65820310532096
Interest coverage ratio: 1.8539807841101632
COGS to revenue (%): 1.7162922755097718
SG&A to revenue (%): 0.7199790428273691
Free cash flow (dilution-adjusted): 263916.5367550066
Buyback yield (%): 0
Retained earnings: 6322400.767478115
Inventory turnover: 1.7667050005948368
Receivables turnover: 4.095130291425258
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.70224104296522
FCF margin (%): 0.42392045520211724
Revenue growth (%): 28.794415746409957
Rule of 40 score: 29.218336201612075
Financial ratios for KAPSTON.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 9416137.12374582
Buffett classification: The Gruesome
Stock price: 1.6680602006688965
Shares outstanding: 30432183
Book value: 9416137.123745818
P/B ratio: 5.391033776872054
Market cap (USD): 50762713.28177258
Debt to equity: 1.6331916394251569
Current ratio: 1.3608852938110827
Quick ratio: 1.3298295045267838
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KAPSTON.NS — quarterly report dated 2024-12-31
Total revenue: 21278633.87341182
Gross profit: 21092539.923067953
Operating income: 793449.1199440494
Net income: 527858.7247930993
Capital expenditures: 0
Depreciation & amortization: 153922.3685744259
Owner earnings: 681781.0933675253
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.0258771418580253
P/E ratio: 29.19903613448162
Shares outstanding: 30432183
Market cap (USD): 61651863.916540384
Effective tax rate (%): -23.060409250251364
Interest coverage ratio: 2.0349167438940543
COGS to revenue (%): 0.8745577909322079
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KAPSTON.NS — annual report dated 2025-03-31
Total revenue: 80597568.38905774
Gross profit: 79703121.34673837
Operating income: 3092728.5480476967
Net income: 2085644.1430909515
Capital expenditures: 4558802.89922843
Operating cash flow: -974210.8954874912
Depreciation & amortization: 525450.0818330605
Net tangible assets: 10390261.86579378
Owner earnings: -1947708.6743044183
Return on net tangible assets (%): -18.745520560136722
Capex to operating income (%): 147.4039130303305
Buffett classification: The Gruesome
Stock price: 1.7263391294200026
P/E ratio: 25.189468913287758
Shares outstanding: 30432183
Book value: 10390250.175356556
P/B ratio: 5.056304460423384
Market cap (USD): 52536268.3065702
Debt to equity: 1.9001082380156216
Current ratio: 1.359211565328312
Quick ratio: 1.3307829678673389
Effective tax rate (%): -18.62495428704412
Interest coverage ratio: 2.165654316540873
COGS to revenue (%): 1.1097692650003277
SG&A to revenue (%): 0.5568935337457698
Free cash flow (dilution-adjusted): -5544704.231938274
Buyback yield (%): 0
Retained earnings: 8248667.290156651
Inventory turnover: 1.6347805649331226
Receivables turnover: 4.20307467583733
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.734159642960243
FCF margin (%): -6.879493194103664
Revenue growth (%): 29.461223990637176
Rule of 40 score: 22.581730796533513
Financial ratios for KAPSTON.NS — quarterly report dated 2025-03-31
Total revenue: 21658300.21042787
Gross profit: 21446527.94014496
Operating income: 964425.9995323825
Net income: 707552.0224456394
Capital expenditures: 0
Depreciation & amortization: 133200.84171148
Net tangible assets: 10390261.86579378
Owner earnings: 840752.8641571193
Return on net tangible assets (%): 8.091738928399844
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.7263391294200026
P/E ratio: 18.562687491507567
Shares outstanding: 30432183
Book value: 10390250.175356556
P/B ratio: 5.056304460423384
Market cap (USD): 52536268.3065702
Debt to equity: 1.9001082380156216
Current ratio: 1.359211565328312
Quick ratio: 1.3307829678673389
Effective tax rate (%): -18.17400812246173
Interest coverage ratio: 2.4714499700419412
COGS to revenue (%): 0.977788045346911
Buyback yield (%): 0
Retained earnings: 8248667.290156651
Inventory turnover: 0.3870561087133029
Receivables turnover: 1.1294565699142172
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.153833530138843
Revenue growth (%): 1.7842608659687138
Rule of 40 score: 1.7842608659687138
Financial ratios for KAPSTON.NS — quarterly report dated 2025-06-30
Total revenue: 22314533.11490756
Gross profit: 22098900.070208285
Operating income: 961432.2490053826
Net income: 717247.8352445589
Capital expenditures: 0
Depreciation & amortization: 106915.51603089165
Owner earnings: 824163.3512754506
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8618066931897967
P/E ratio: 29.01625635226039
Shares outstanding: 30432183
Market cap (USD): 56658841.99777675
Effective tax rate (%): -11.37639683837558
Interest coverage ratio: 2.4859010044777925
COGS to revenue (%): 0.9663345568956476
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 3.0299372439381553
Rule of 40 score: 3.0299372439381553
Financial ratios for KAPSTON.NS — quarterly report dated 2025-09-30
Total revenue: 23749052.987598646
Gross profit: 23539368.658399098
Operating income: 1016617.8128523112
Net income: 795400.2254791432
Capital expenditures: 0
Depreciation & amortization: 105039.45885005637
Net tangible assets: 11474926.719278466
Owner earnings: 900439.6843291996
Return on net tangible assets (%): 7.847019038617603
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8526493799323562
P/E ratio: 20.516360421974117
Shares outstanding: 30432183
Book value: 11474926.719278466
P/B ratio: 4.9133355135258885
Market cap (USD): 56380164.96493799
Debt to equity: 1.7234193270755513
Current ratio: 1.3931534906222343
Quick ratio: 1.3677776283233054
Effective tax rate (%): -10.496476115896632
Interest coverage ratio: 2.773731159643187
COGS to revenue (%): 0.882916591701752
Buyback yield (%): 0
Inventory turnover: 0.41423162583518935
Receivables turnover: 1.135328648745369
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.185087583320416
Revenue growth (%): 6.4286349407540815
Rule of 40 score: 6.4286349407540815
Financial ratios for KAPSTON.NS — quarterly report dated 2025-12-31
Total revenue: 23688893.839812856
Gross profit: 23496368.497270804
Operating income: 1136136.7940291858
Net income: 827559.3182577699
Capital expenditures: 0
Depreciation & amortization: 114325.49849615686
Owner earnings: 941884.8167539268
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.227136014258661
P/E ratio: 22.23817625501338
Shares outstanding: 30432183
Market cap (USD): 67776610.75181018
Effective tax rate (%): -4.12491064795997
Interest coverage ratio: 3.127502989788722
COGS to revenue (%): 0.8127240716427344
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.25331177549355066
Rule of 40 score: -0.25331177549355066
Financial ratios for KEX — annual report dated 2021-12-31
Capital expenditures: 0
Operating cash flow: 321576000
Buffett classification: The Gruesome
Stock price: 59.42
Shares outstanding: 53472000
Market cap (USD): 3177306240
Free cash flow (dilution-adjusted): 321576000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KEX — annual report dated 2022-12-31
Total revenue: 2784754000
Gross profit: 522370000
Operating income: 184607000
Net income: 122761000
Capital expenditures: 36905000
Operating cash flow: 294128000
Depreciation & amortization: 201443000
Net tangible assets: 2552666000
Owner earnings: 287299000
Return on net tangible assets (%): 11.254860604560095
Capex to operating income (%): 19.991116263196954
Buffett classification: The Great
Stock price: 64.35
P/E ratio: 28.02944909213838
Shares outstanding: 53472000
Book value: 3045168000
P/B ratio: 1.1299616966945665
Market cap (USD): 3440923199.9999995
Debt to equity: 0.41317983112918566
Current ratio: 1.886896077060466
Quick ratio: 1.167727348461609
Effective tax rate (%): 25.58811941203213
Interest coverage ratio: 4.140284381447923
COGS to revenue (%): 81.24179011862448
SG&A to revenue (%): 10.869613617576274
Free cash flow (dilution-adjusted): 107657000
Buyback yield (%): 0.6655481296414869
Retained earnings: 2468730000
Inventory turnover: 4.89854670800783
Receivables turnover: 4.6570751987584496
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.757729668267746
FCF margin (%): 3.865942916322232
Rule of 40 score: 3.865942916322232
Financial ratios for KEX — annual report dated 2023-12-31
Total revenue: 3091640000
Gross profit: 700062000
Operating income: 330083000
Net income: 222935000
Capital expenditures: 26081000
Operating cash flow: 540228000
Depreciation & amortization: 211156000
Net tangible assets: 2703756000
Owner earnings: 408010000
Return on net tangible assets (%): 15.090488934652388
Capex to operating income (%): 7.9013460250906595
Buffett classification: The Great
Stock price: 78.48
P/E ratio: 18.823794200103173
Shares outstanding: 53472000
Book value: 3186677000
P/B ratio: 1.3168835624068584
Market cap (USD): 4196482560
Debt to equity: 0.37303623806240793
Current ratio: 1.679741637626795
Quick ratio: 1.0073646594011498
Effective tax rate (%): 24.214194645133873
Interest coverage ratio: 6.346773573296416
COGS to revenue (%): 77.35628986557298
SG&A to revenue (%): 10.842562523450336
Free cash flow (dilution-adjusted): 123557000
Buyback yield (%): 2.6880369067946273
Retained earnings: 2691665000
Inventory turnover: 5.263283222085041
Receivables turnover: 5.342240408075809
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.540957299874248
FCF margin (%): 3.996487301238178
Revenue growth (%): 11.02021938023969
Rule of 40 score: 15.016706681477867
Financial ratios for KEX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 122.43
Shares outstanding: 53472000
Market cap (USD): 6546576960
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KEX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 105.8
Shares outstanding: 53472000
Market cap (USD): 5657337600
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KEX — annual report dated 2024-12-31
Total revenue: 3265876000
Gross profit: 825200000
Operating income: 453193000
Net income: 286896000
Capital expenditures: 20396000
Operating cash flow: 756494000
Depreciation & amortization: 240322000
Net tangible assets: 2878659000
Owner earnings: 506822000
Return on net tangible assets (%): 17.6061839905317
Capex to operating income (%): 4.5005108198935115
Buffett classification: The Great
Stock price: 105.8
P/E ratio: 19.719123306006356
Shares outstanding: 53472000
Book value: 3353248000
P/B ratio: 1.6871217398772773
Market cap (USD): 5657337600
Debt to equity: 0.31576698174426704
Current ratio: 1.454310496180349
Quick ratio: 0.9182146925565462
Effective tax rate (%): 20.91365436938166
Interest coverage ratio: 9.224551690447598
COGS to revenue (%): 74.73265978255145
SG&A to revenue (%): 10.321794213864825
Free cash flow (dilution-adjusted): 398285000
Buyback yield (%): 3.0857978141520137
Retained earnings: 2978372000
Inventory turnover: 6.196213232867392
Receivables turnover: 6.084595105683332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.856270784075429
FCF margin (%): 12.195349731588093
Revenue growth (%): 5.635714378129407
Rule of 40 score: 17.831064109717502
Financial ratios for KEX — quarterly report dated 2025-03-31
Total revenue: 785659000
Gross profit: 209593000
Operating income: 105476000
Net income: 76270000
Capital expenditures: 78687000
Operating cash flow: 36541000
Depreciation & amortization: 63730000
Net tangible assets: 2855012000
Owner earnings: 61313000
Return on net tangible assets (%): 2.1475566477478907
Capex to operating income (%): 74.60180514998672
Buffett classification: The Good
Stock price: 101.01
P/E ratio: 17.70423075914514
Shares outstanding: 53472000
Book value: 3327754000
P/B ratio: 1.62307872517019
Market cap (USD): 5401206720
Debt to equity: 0.3846546349279424
Current ratio: 1.5778797938111864
Quick ratio: 0.9556115737142187
Effective tax rate (%): 23.99071185832594
Interest coverage ratio: 10.010059789313846
COGS to revenue (%): 73.3226501573838
SG&A to revenue (%): 12.12828975420634
Free cash flow (dilution-adjusted): -49993000
Buyback yield (%): 1.8787098006128526
Retained earnings: 3054358000
Inventory turnover: 1.3251852976494458
Receivables turnover: 1.4191304504895055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9841166828253778
FCF margin (%): -6.3631931919573255
Rule of 40 score: -6.3631931919573255
Financial ratios for KEX — quarterly report dated 2025-06-30
Total revenue: 855455000
Gross profit: 226547000
Operating income: 130159000
Net income: 94378000
Capital expenditures: 71473000
Operating cash flow: 93922000
Depreciation & amortization: 65670000
Net tangible assets: 2916199000
Owner earnings: 88575000
Return on net tangible assets (%): 3.037344159297771
Capex to operating income (%): 54.912069084734824
Buffett classification: The Good
Stock price: 113.41
P/E ratio: 35.53665744690826
Shares outstanding: 53472000
Book value: 3389890000
P/B ratio: 1.7889251627633933
Market cap (USD): 6064259520
Debt to equity: 0.38286050579812325
Current ratio: 1.7440882940347955
Quick ratio: 1.1167270334988086
Effective tax rate (%): 23.84449034923504
Interest coverage ratio: 10.22458758837392
COGS to revenue (%): 73.51736795038897
SG&A to revenue (%): 10.035127505245747
Free cash flow (dilution-adjusted): 19149000
Buyback yield (%): 0.514489854814129
Retained earnings: 3148635000
Inventory turnover: 1.4753920683143116
Receivables turnover: 1.3655511817308215
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.410125121562638
FCF margin (%): 2.238457896674869
Revenue growth (%): 8.883752365848288
Rule of 40 score: 11.122210262523158
Financial ratios for KEX — quarterly report dated 2025-09-30
Total revenue: 871161000
Gross profit: 223797000
Operating income: 126217000
Net income: 92738000
Capital expenditures: 67280000
Operating cash flow: 227531000
Depreciation & amortization: 66873000
Net tangible assets: 2891475000
Owner earnings: 92331000
Return on net tangible assets (%): 3.1932145358337873
Capex to operating income (%): 53.30502230285936
Buffett classification: The Good
Stock price: 83.45
P/E ratio: 16.941820749774095
Shares outstanding: 53472000
Book value: 3363241000
P/B ratio: 1.3267673651694898
Market cap (USD): 4462238400
Debt to equity: 0.37240804331298294
Current ratio: 1.6962297263699782
Quick ratio: 1.076173274639133
Effective tax rate (%): 24.56522800110625
Interest coverage ratio: 10.662020611589796
COGS to revenue (%): 74.31048910591727
SG&A to revenue (%): 10.079881904722548
Free cash flow (dilution-adjusted): 156831000
Buyback yield (%): 2.6884489183724476
Retained earnings: 3241131000
Inventory turnover: 1.5268883144328924
Receivables turnover: 1.405173178572408
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.346132905955977
FCF margin (%): 18.00252766136225
Revenue growth (%): 1.835982021263538
Rule of 40 score: 19.83850968262579
Financial ratios for KEX — quarterly report dated 2025-12-31
Total revenue: 851775000
Gross profit: 223486000
Operating income: 129644000
Net income: 92029000
Capital expenditures: 47033000
Operating cash flow: 312210000
Depreciation & amortization: 67853000
Net tangible assets: 2911599000
Owner earnings: 112849000
Return on net tangible assets (%): 3.875842792912074
Capex to operating income (%): 36.27857826046713
Buffett classification: The Good
Stock price: 110.18
P/E ratio: 16.576523106790653
Shares outstanding: 53472000
Book value: 3382793000
P/B ratio: 1.7416214826032808
Market cap (USD): 5891544960
Debt to equity: 0.3354922988193484
Current ratio: 1.5255745027769758
Quick ratio: 0.9622164285997362
Effective tax rate (%): 25.904366239140764
Interest coverage ratio: 11.552664409196222
COGS to revenue (%): 73.76231986146577
SG&A to revenue (%): 10.256229638108655
Free cash flow (dilution-adjusted): 262181000
Buyback yield (%): 1.7238432480705366
Retained earnings: 3332941000
Inventory turnover: 1.5785124589850914
Receivables turnover: 1.568302710823963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.445411420609293
FCF margin (%): 30.780546505826067
Revenue growth (%): -2.225306229273349
Rule of 40 score: 28.555240276552716
Financial ratios for KEX — annual report dated 2025-12-31
Total revenue: 3364050000
Gross profit: 883423000
Operating income: 491496000
Net income: 355415000
Capital expenditures: 31009000
Operating cash flow: 670204000
Depreciation & amortization: 264126000
Net tangible assets: 2911599000
Owner earnings: 588532000
Return on net tangible assets (%): 20.213360424976106
Capex to operating income (%): 6.30910526230122
Buffett classification: The Great
Stock price: 110.18
P/E ratio: 16.576523106790653
Shares outstanding: 53472000
Book value: 3382793000
P/B ratio: 1.7416214826032808
Market cap (USD): 5891544960
Debt to equity: 0.3354922988193484
Current ratio: 1.5255745027769758
Quick ratio: 0.9622164285997362
Effective tax rate (%): 24.606289190771555
Interest coverage ratio: 10.609277527143998
COGS to revenue (%): 73.73930232903791
SG&A to revenue (%): 10.591548877097546
Free cash flow (dilution-adjusted): 388168000
Buyback yield (%): 6.011988407197015
Retained earnings: 3332941000
Inventory turnover: 6.232324019033933
Receivables turnover: 6.193946446358901
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.27084887525674
FCF margin (%): 11.538710780160818
Revenue growth (%): 3.0060541184049856
Rule of 40 score: 14.544764898565804
Financial ratios for KRC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 51.15
Shares outstanding: 116278807
Market cap (USD): 5947660978.05
Buyback yield (%): 0.3680102157937085
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KRC — annual report dated 2022-12-31
Total revenue: 1096987000
Gross profit: 775930000
Operating income: 324677000
Net income: 259493000
Capital expenditures: 0
Operating cash flow: 592235000
Depreciation & amortization: 358383000
Net tangible assets: 5366623000
Owner earnings: 617876000
Return on net tangible assets (%): 11.513311071040391
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 31.07
P/E ratio: 13.922466245679075
Shares outstanding: 116278807
Book value: 5674961000
P/B ratio: 0.6366180372851902
Market cap (USD): 3612782533.4900002
Debt to equity: 0.7732194106708399
Current ratio: 1.1648924575906359
Quick ratio: 1.1648924575906359
Interest coverage ratio: 3.8524525973563684
COGS to revenue (%): 29.267165426755287
SG&A to revenue (%): 8.536290767347289
Free cash flow (dilution-adjusted): -22721000
Buyback yield (%): 0.6348015632661239
Retained earnings: 265118000
Receivables turnover: 2.320275898245072
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2264591172112436
FCF margin (%): -2.0712187108871847
Rule of 40 score: -2.0712187108871847
Financial ratios for KRC — annual report dated 2023-12-31
Total revenue: 1129694000
Gross profit: 778624000
Operating income: 329082000
Net income: 238288000
Capital expenditures: 0
Operating cash flow: 602589000
Depreciation & amortization: 356302000
Net tangible assets: 5373647000
Owner earnings: 594590000
Return on net tangible assets (%): 11.064924808049357
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 34.21
P/E ratio: 16.69365636318237
Shares outstanding: 116278807
Book value: 5659693000
P/B ratio: 0.7028469543259679
Market cap (USD): 3977897987.4700003
Debt to equity: 0.8927570806402396
Current ratio: 1.8587190922147305
Quick ratio: 1.8587190922147305
Interest coverage ratio: 2.88122504727884
COGS to revenue (%): 31.076557014554385
SG&A to revenue (%): 8.344206484233784
Free cash flow (dilution-adjusted): 21912000
Buyback yield (%): 0.29148560462141426
Retained earnings: 221149000
Receivables turnover: 2.380367813766888
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.071965784774762
FCF margin (%): 1.9396402919728706
Revenue growth (%): 2.9815303189554663
Rule of 40 score: 4.921170610928337
Financial ratios for KRC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.81
Shares outstanding: 116278807
Market cap (USD): 4047665271.67
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KRC — annual report dated 2024-12-31
Total revenue: 1135629000
Gross profit: 762758000
Operating income: 335502000
Net income: 232954000
Capital expenditures: 19354000
Operating cash flow: 541149000
Depreciation & amortization: 357248000
Net tangible assets: 5323479000
Owner earnings: 570848000
Return on net tangible assets (%): 10.723213146891347
Capex to operating income (%): 5.7686690392307645
Buffett classification: The Great
Stock price: 36.88
P/E ratio: 18.40862317092645
Shares outstanding: 116278807
Book value: 5608869000
P/B ratio: 0.7645681156325812
Market cap (USD): 4288362402.1600003
Debt to equity: 0.8426274530569353
Current ratio: 1.1808145201233444
Quick ratio: 1.1808145201233444
Interest coverage ratio: 2.309236201449545
COGS to revenue (%): 32.83387444315001
SG&A to revenue (%): 6.258558032596913
Free cash flow (dilution-adjusted): 22456000
Buyback yield (%): 0.6444418033811707
Retained earnings: 171212000
Receivables turnover: 2.452608799880785
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.246252366702222
FCF margin (%): 1.977406353659514
Revenue growth (%): 0.5253635055156529
Rule of 40 score: 2.502769859175167
Financial ratios for KRC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.88
Shares outstanding: 116278807
Market cap (USD): 4288362402.1600003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0